Materials

KT Kazumi Take
TM Taisuke Mochida
TM Toshiyuki Maki
YS Yoshinori Satomi
MH Megumi Hirayama
MN Masanori Nakakariya
NA Nobuyuki Amano
RA Ryutaro Adachi
KS Kenjiro Sato
TK Tomoyuki Kitazaki
ST Shiro Takekawa
request Request a Protocol
ask Ask a question
Favorite

Structure of compA was shown in Fig 1A. Synthesis of compA was reported previously [20]. This compound exhibited selectivity (greater than 30,000-fold) against related acyltransferases (MGAT3, DGAT1, DGAT2, and ACAT1) [20]. Glycerol-labeled MG (2-oleyl-[1, 1, 2, 3, 3 d5]-glycerol) and fatty acid-labeled MG (2-[17, 17, 18, 18, 18 d5]-oleoylglycerol) were purchased from CURACHEM (Gyeonggi-do, Korea). Organic solvents were purchased from WAKO (Osaka, Japan).

Fasted C57BL/6J mice were given a liquid meal orally with intraperitoneal injection of Pluronic F-127 to inhibit plasma TG lipolysis. (A) Structure of compA. Plasma samples were collected at 0, 2, and 4 h after oral gavage of a liquid meal. (B) Time course of changes in plasma chylomicron TG (CM/TG) levels and (C) postprandial TG excursion of 3 or 10 mg/kg compA at 6 h after dosing. (D) Time course of changes in plasma TG levels and (E) postprandial TG excursion of 30 mg/kg compA at 16 h after dosing. n = 6 (B, C), and n = 7 (D, E). #: P < 0.025 vs. vehicle group by one-tailed Williams’ test. **: P < 0.01, ***: P < 0.001 vs. vehicle group by Student’s t-test.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A